0001209191-17-023841.txt : 20170331
0001209191-17-023841.hdr.sgml : 20170331
20170331160909
ACCESSION NUMBER: 0001209191-17-023841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170329
FILED AS OF DATE: 20170331
DATE AS OF CHANGE: 20170331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17730431
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2017-03-29
4
M
0
5719
38.80
A
105054
D
Common Stock
2017-03-29
4
M
0
17156
37.86
A
122210
D
Common Stock
2017-03-29
4
M
0
29032
48.74
A
151242
D
Common Stock
2017-03-29
4
M
0
28593
45.11
A
179835
D
Common Stock
2017-03-29
4
S
0
51468
106.30
D
128367
D
Common Stock
2017-03-29
4
S
0
29032
110.00
D
99335
D
Common Stock
882
I
401k
Stock Option (Right to Buy)
38.80
2017-03-29
4
M
0
5719
38.80
D
2021-02-02
Common Stock
5719
0
D
Stock Option (Right to Buy)
37.86
2017-03-29
4
M
0
17156
37.86
D
2022-02-01
Common Stock
17156
0
D
Stock Option (Right to Buy)
48.74
2017-03-29
4
M
0
29032
48.74
D
2022-07-24
Common Stock
29032
0
D
Stock Option (Right to Buy)
45.11
2017-03-29
4
M
0
28593
45.11
D
2023-02-04
Common Stock
28593
0
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Fully vested.
Omar White, Attorney-In-Fact
2017-03-31